Stephen Craycraft

Stephen Craycraft started their work experience in 2003 as an Analytical Chemist at GlaxoSmithKline, where they worked until 2004. Stephen then moved on to work as an Analytical Chemist at Pfizer from 2004 to 2005. After that, they joined Resolute Communications as an Account Executive, focusing on Pharmaceutical Public Relations, Communications, and Marketing, from 2005 to 2006. Following this, they worked at Pfizer again as a Scientist in Respiratory Product R&D from 2006 to 2012. Stephen then joined Mylan as a Senior Scientist in Pharmaceutical Science R&D & Clinical Operations from 2012 to 2015. From 2015 to 2017, they worked as a Business Development Manager at LGC's Drug Development Services. After that, they served as an Associate Director of Business Development at Drug Development Solutions from 2017 to 2023. Currently, they hold the position of Executive Director of Business Development at Resolian, starting in 2023.

Stephen Craycraft completed their Bachelor of Science (BSc Hons) in Applied and Human Biology at Aston University from 1999 to 2003. Stephen then pursued an MSc in Pharmaceutical Analysis and Quality Control at King's College London from 2007 to 2009. Later, they obtained a Master of Business Administration (MBA) degree in Entrepreneurship from Imperial College London, which they completed from 2012 to 2014.